100+
paid subscribers
2K+
free subscribers

BowTiedBiotech

About the Substack

Daily Biotech Public & Private Market Updates, Company Building, Financing, Exit Strategies, and Emerging Science Trends

Free Subscription Benefits

  • WEEKLY biotech public/private market updates

Paid Subcription Benefits

  • INSIDER INSIGHTS to SHARPEN your stock picking & company building skills
  • TRADE BIOTECH STOCKS with material event alerts (data readouts, approvals)
  • GIVE to GET: Opportunity to support the hours we put into sharing our content

Paid Subscription Plans

  • $54.98 a year
  • $5.30 a month

About BowTiedBiotech

Weekly Biotech Public & Private Market Updates, Company Building, Financing, Exit Strategies, and Emerging Science Trends

Subscriber Growth

The number of free subscribers for BowTiedBiotech over time since it was added to the directory.

Is this your Substack? Submit changes.

BowTiedBiotech's recommended Substacks

BowTied Bull logo
BowTied Bull

BowTied Bull

The #1 Paid Crypto Substack. No non-sense writing style covering: 1) Crypto, 2) Tech Stocks, 3) WiFi money and 4) Real Estate. Written by anon Ex-Wall St and Tech Individuals. SPONSOR FREE.

1000+
paid subscribers
106K+
free subscribers
Big Pharma Sharma logo
Big Pharma Sharma

Big Pharma Sharma

12+ year BioPharma strategy pro, facetiously named "Big Pharma Sharma". Delivering weekly insights, analyses, and takes here from an insider's perspective.

Asymmetric Learning - Pharmaceutical Innovation  logo
Mike Rea, IDEA Pharma

Asymmetric Learning - Pharmaceutical Innovation

Innovations in Pharmaceutical Innovation A blog/ part-work from Mike Rea, CEO of IDEA Pharma, exploring pharmaceutical innovation in general, and more specifically the approach to using the learning process for competitive advantage